Debt-to-equity of ALTEROLA BIOTECH INC. from 31 Mar 2019 to 30 Sep 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
ALTEROLA BIOTECH INC. quarterly Debt-to-equity in % history and change rate from 31 Mar 2019 to 30 Sep 2024.
  • ALTEROLA BIOTECH INC. Debt-to-equity for the quarter ending 30 Sep 2024 was -143%, a 542% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

ALTEROLA BIOTECH INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2024 -143% -175% -542% 30 Sep 2024
Q2 2024 -126% -145% -741% 30 Jun 2024
Q1 2024 138% +122% +739% 31 Mar 2024
Q4 2023 51% +38% +279% 31 Dec 2023
Q3 2023 32% +16% +98% 30 Sep 2023
Q2 2023 20% -5.2% -21% 30 Jun 2023
Q1 2023 16% -40% -71% 31 Mar 2023
Q4 2022 14% +144% 31 Dec 2022
Q3 2022 16% +130% 30 Sep 2022
Q2 2022 25% +133% 30 Jun 2022
Q1 2022 57% +159% 31 Mar 2022
Q4 2021 -130% -25% -24% 31 Dec 2021
Q3 2021 -113% -7.6% -7.2% 30 Sep 2021
Q2 2021 -108% -1.8% -1.7% 30 Jun 2021
Q1 2021 -103% +4.8% +4.5% 31 Mar 2021
Q4 2020 -105% +4% +3.6% 31 Dec 2020
Q3 2020 -106% +6% +5.4% 30 Sep 2020
Q2 2020 -107% +18% +14% 30 Jun 2020
Q1 2020 -108% +55% +34% 31 Mar 2020
Q4 2019 -109% 31 Dec 2019
Q3 2019 -112% 30 Sep 2019
Q2 2019 -124% 30 Jun 2019
Q1 2019 -163% 31 Mar 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.